However, the reduction in HEK 293T cells was considerably smaller following siRNA treatment (~15% non-viable), and not significantly different from control siRNA treated or untreated controls, suggesting a specific role of SRPX in glioblastoma tumorigenesis. This evidence concerns the gene SRPX and glioblastoma.